Dr. Tara Lynn Baum MD

Recommended Articles

• Laparoscopy for Endometriosis

  What is laparoscopy?Laparoscopy is a common procedure used for diagnosing and removing mild to moderate endometriosis. The surgeon puts a small viewing instrument known as laparoscope through a small abdominal cut. If more access is needed, the surgeon makes a small cut or two on the abdomen to...

• Risk of Multiple Sclerosis Reduced by Breast-Feeding, Study Suggests

  Women are twice as likely as men to develop Multiple Sclerosis in their lifetime, and recent studies have been focused on discovering links, if they exist, between MS and motherhood. The relationship between women and MS has become increasingly complicated as fluctuations in risk have been...

• Hair Loss After Pregnancy

  IntroductionMost women notice having a thicker hair during pregnancy. However, it can totally be the opposite after giving birth. After pregnancy, they may notice frequent hair fall or hair loss. This scenario is quite common for most women during and after pregnancy. Continue reading below to...

• Chlamydia Doubled Ovarian Cancer Risk, Study Shows

  Chlamydia trachomatis, commonly known as chlamydia, is a type of sexually transmitted infection (STI). In the United States, approximately 1.5 million cases of chlamydia are reported on an annual basis, making it the most commonly reported type of bacterial infection – according to the Centers for...

• What are Fibroids?

  What are Fibroids?Fibroids are muscular tumors that grow in a woman's uterine walls. Fibroids are also known as leiomyoma (leye-oh-meye-OH-muh), or myoma. In most cases, these muscular tumors are benign. Fibroids can grow as a single tumor, or develop into multiple tumors in the uterus. They can...

• Sleep Positioners May Increase a Baby's Risk of Death

  A warning has been issued by the FDA and the Consumer Product Safety Commission (CPSC) against the use of sleep-positioning devices for babies. About 12 deaths have been reported with the use of these devices in the last 13 years.FDA principal deputy commissioner, Joshua Sharfstein, reported that...